Your best source on science and technology news from Washington state

Provided by AGP

Sci-Tech Seattle
Got News to Share?
Got News to Share? Explore more publications!

Sci-Tech Seattle: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Seattle.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 5, 2026

Enovix Corporation Appoints Steve Bakos as Senior Vice President of Worldwide Sales to Support Commercial Scale-up and Revenue Growth
May. 5, 2026

Enovix Corporation Appoints Steve Bakos as Senior Vice President of Worldwide Sales to Support Commercial Scale-up and Revenue Growth

Indeterminate GlobeNewswire
Core AI Appoints Sonali Garg, Former Meta Data Center Leader and COO of Allianca Group, to Advisory Board
May. 5, 2026

Core AI Appoints Sonali Garg, Former Meta Data Center Leader and COO of Allianca Group, to Advisory Board

Indeterminate GlobeNewswire
Kura Oncology to Report First Quarter 2026 Financial Results
May. 5, 2026

Kura Oncology to Report First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Intellia Therapeutics to Participate in Upcoming Investor Conferences
May. 5, 2026

Intellia Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
BridgeBio to Present Primary Results from the Phase 3 CALIBRATE Trial at 2026 ECE
May. 5, 2026

BridgeBio to Present Primary Results from the Phase 3 CALIBRATE Trial at 2026 ECE

Indeterminate GlobeNewswire
Tris Pharma Appoints Jim Potenziano, Ph.D. as Chief Science and Development Officer
May. 5, 2026

Tris Pharma Appoints Jim Potenziano, Ph.D. as Chief Science and Development Officer

Indeterminate GlobeNewswire
Rumble Announces Receipt of all Regulatory Approvals for Business Combination with Northern Data
May. 5, 2026

Rumble Announces Receipt of all Regulatory Approvals for Business Combination with Northern Data

Indeterminate GlobeNewswire
Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy
May. 5, 2026

Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy

Indeterminate GlobeNewswire
EarthDaily Selected by National Reconnaissance Office (NRO) for Commercial Optical Earth Observation Contract
May. 5, 2026

EarthDaily Selected by National Reconnaissance Office (NRO) for Commercial Optical Earth Observation Contract

Indeterminate GlobeNewswire
Joveo Introduces AI Scheduling, Automating Interview Coordination for Candidates and Recruiting Teams
May. 5, 2026

Joveo Introduces AI Scheduling, Automating Interview Coordination for Candidates and Recruiting Teams

Indeterminate GlobeNewswire
Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights
May. 5, 2026

Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire
Sarah Campbell Joins Future Technologies Venture LLC as Chief Operating Officer
May. 5, 2026

Sarah Campbell Joins Future Technologies Venture LLC as Chief Operating Officer

Indeterminate GlobeNewswire
Cellectar Biosciences Reports Positive 12-Month Follow-Up Data from Phase 2b CLOVER WaM Study Demonstrating Durable Responses and Efficacy of Iopofosine I 131 in r/r Waldenström Macroglobulinemia
May. 5, 2026

Cellectar Biosciences Reports Positive 12-Month Follow-Up Data from Phase 2b CLOVER WaM Study Demonstrating Durable Responses and Efficacy of Iopofosine I 131 in r/r Waldenström Macroglobulinemia

Indeterminate GlobeNewswire
uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates
May. 5, 2026

uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates

Indeterminate GlobeNewswire
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May. 5, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May. 5, 2026

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Dupixent® (dupilumab) Demonstrates Improved Esophageal Function in Eosinophilic Esophagitis (EoE) Phase 4 Trial
May. 5, 2026

Dupixent® (dupilumab) Demonstrates Improved Esophageal Function in Eosinophilic Esophagitis (EoE) Phase 4 Trial

Indeterminate GlobeNewswire
Kymera Therapeutics Presents New Preclinical IBD Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at Digestive Disease Week
May. 5, 2026

Kymera Therapeutics Presents New Preclinical IBD Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at Digestive Disease Week

Indeterminate GlobeNewswire
FactSet Increases Dividend
May. 5, 2026

FactSet Increases Dividend

Indeterminate GlobeNewswire
Orvida Pharma to Present Functional Endpoint Development Data in Rare Palmoplantar Skin Disorders at the 83rd Annual Meeting of the Society for Investigative Dermatology and the 2026 Epidermal Differentiation Disorders Symposium
May. 5, 2026

Orvida Pharma to Present Functional Endpoint Development Data in Rare Palmoplantar Skin Disorders at the 83rd Annual Meeting of the Society for Investigative Dermatology and the 2026 Epidermal Differentiation Disorders Symposium

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn

Sign up for:

Sci-Tech Seattle

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.